Pharmafile Logo
Pharmafocus logo
Advanced Search

FDA approves AbbVie’s Mavyret for children with Hepatitis C (HCV)

May 1, 2019
Research and Development AbbVie, HCV, hepatitis C, mavyret, pharma

The FDA has approved AbbVieโ€™s Mavyret tables (glecaprevir/pibrentasvir) as a treatment for hepatitis C (HCV) in children aged 12 to 17 …

News
dw-anzcxqaqavhl

FDA refuses to review Nabriva’s injectable antibiotic for urinary tract infections

May 1, 2019
Research and Development, Sales and Marketing Contepo, Nabriva, pharma, urinary tract infections

Biopharma firm Nabriva Therapeutics has revealed that its antibiotic Contepo (fosfomycin) has been rejected for review by the FDA as …

News
smoking

Diabetes drug may help people quit smoking

May 1, 2019
Research and Development UTHealth, clinical trials, diabetes, smoking smoking cessation

A diabetes drug may help people quit smoking, according to researchers at the University of Texas Health Science Center at …

News
robin_washington

Gilead’s CFO and Executive Vice President to depart in 2020

May 1, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment, pharma

Gilead has announced that Robin Washington, the companyโ€™s Senior Vice President and Chief Financial Officer of more than a decade, …

News
astrocyte5

Scientists identify new form of dementia

May 1, 2019
Research and Development AD, Alzheimer's, dementia, late, neuroscience

A team of scientists from Britain and the United States have described a new form of dementia, according to a …

News
gsk_boronia_australia

GSK’s Benlysta becomes first FDA-approved IV therapy for paediatric lupus

April 30, 2019
Manufacturing and Production, Sales and Marketing Benlysta, FDA, GSK, Lupus, US, pharma

GSK has scored approval in the US with Benlysta (belimumab) for the treatment of systemic lupus erythematosus (SLE) in paediatric …

News

Two thirds of MPs believe NHS should spend less on medicines

April 30, 2019
Manufacturing and Production Long Term Plan, MPs, NHS, UK, government, health, public health

Nearly two thirds (64%) of MPs believe the NHS should direct more resources towards prevention, over funding for new treatments, …

News
donald_trump-_image_credit_gage_skidmore

Donald Trump says he will not accept campaign money from pharma

April 30, 2019
Manufacturing and Production Donald Trump, USA, campaign contributionss, pharma, politics

President Donald Trump has said he will not accept money from pharmaceutical companies in the run up to the 2020 …

News

New Phase 3 data confirms safety and efficacy of UCB’s Cimzia in plaque and psoriatic arthritis

April 30, 2019
Manufacturing and Production, Research and Development Cimzia, UCB Pharma, pharma, plaque psoriasis, psoriasis

New Phase 3 data has been released by UCB Pharma on the safety of Cimzia (certolizumab pegol) in the treatment …

News
482px-sem_blood_cells

Stanford scientists develop test for ME

April 30, 2019
Manufacturing and Production CFS, ME, diagnosis, electric curernt, immune system, nanoelectronic assay

Scientists from Stanford University have, for the first time, developed a test for Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The blood …

News

The price of access: Can the NHS afford Orkambi?

April 29, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, NHS, NICE, Orkambi, UK, Vertex, access, cystic fibrosis, feature, pharma, pricing

The impasse over access to Vertexโ€™s Orkambi for cystic fibrosis patients in England and Wales has revealed the cracks in …

Feature
shutterstock_243110086

Sanofi and Lexicon’s Zynquista scores EU approval for type 1 diabetes patients

April 29, 2019
Sales and Marketing Lexicon, Sanofi, Type 1 diabetes, Zynquista, diabetes, pharma

The European Commission has authorised the use of Sanofi and Lexiconโ€™s Zynquista (sotagliflozin) in Europe in the treatment of specific …

News

Gilead subsidiary Kite Pharma to open CAR-T manufacturing facility in Maryland

April 29, 2019
Manufacturing and Production, Sales and Marketing CAR-T, Gilead, Manufacturing Facility, Maryland, kite pharma

Gilead Sciences subsidiary Kite Pharma has announced plans to open a new CAR-T manufacturing facility in Frederick County, Maryland (US). …

News
credit_-_daniel_leal-olivas-afp

AZ and MSD’s Lynparza secures CHMP nod in first-line BRCA-mutated ovarian cancer

April 29, 2019
Sales and Marketing AstraZeneca, CHMP, Cancer, MSD, lynparza, ovarian cancer, pharma

AstraZeneca and MSDโ€™s Lynparza (olaparib) has received a positive opinion from the EMAโ€™s Committee for Medicinal Products for Human Use …

News

India hits back at claims they are leading source of counterfeit drugs

April 29, 2019
Sales and Marketing

India has rejected claims that they, along with China, are the chief source of counterfeit medicines around the world. In …

News
opioid_pills

Opioids to be labelled with addiction warning in UK

April 29, 2019
Sales and Marketing

All opioid medicines sold in the UK will be labelled with a warning as to the potential for addiction, Health …

News
gilead-sciences

Gilead’s selonsertib crashes at Phase 3 in NASH

April 26, 2019
Medical Communications, Research and Development, Sales and Marketing Gilead, nash, pharma, selonsertib

Gilead has broken the news that its apoptosis signal-regulating kinase 1 (ASK1) inhibitor selonsertib failed to meet its primary endpoint …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

April 26, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Aduro Biotech, Cancer, GSK, ICR, J&J, JJ, Novartis, Sandoz, pharma

The Institute for Cancer Research (ICR) called for new measures to increase the speed with which patients in the UK …

News
richard_saynor

Senior GSK exec Richard Saynor revealed as new Sandoz CEO

April 26, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Novartis has seen a major leadership change within its business, as the company announced that senior GlaxoSmithKline exec Richard Saynor …

Appointment
lilly_building_with_american_flag_web

Eli Lilly to withdraw Lartruvo from market in soft tissue sarcoma following Phase 3 failure

April 26, 2019
Medical Communications, Sales and Marketing Cancer, Eli Lilly, Lartruvo, pharma, soft tissue sarcoma

Eli Lilly has revealed it is to withdraw its platelet-derived growth factor receptor alpha (PDGFR-ฮฑ) blocking antibody Lartruvo (olaratumab) from …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies โ€“ a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026